Results 301 to 310 of about 3,321,367 (333)

Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997
Multidetector SPECT systems equipped with a high-energy, or 511-keV collimator, have been proposed to offer a less expensive alternative to PET in myocardial viability studies with [18F]FDG. The objectives of this investigation included: (a) measuring the physical imaging characteristics of SPECT systems equipped with either a high-energy general ...
E Q, Chen, W J, MacIntyre, R T, Go, R C, Brunken, G B, Saha, C Y, Wong, D R, Neumann, S A, Cook, S P, Khandekar   +8 more
openaire   +1 more source

Chemistry of fluorine-18 radiopharmaceuticals

International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
M S, Berridge, T J, Tewson
openaire   +2 more sources

Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18.

Nuclear Medicine and Biology, 2020
H. Coenen, J. Ermert
semanticscholar   +1 more source

The standardisation of fluorine-18.

Australasian physical & engineering sciences in medicine, 1996
The Australian Nuclear Science and Technology Organisation (ANSTO) maintains and disseminates the Australian standards of activity measurement. The standards include all nuclear medicine gamma-emitters and pure positron emitters. Calibration factors for the ANSTO 4 pi ionisation chamber for pure positron emitters have been traditionally determined from
openaire   +1 more source

A radiosynthesis of fluorine-18 fluoromisonidazole.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1989
A new preparation of [18F]fluoromisonidazole [1H-1-(3-[18F] fluoro-2-hydroxypropyl)-2-nitroimidazole] is presented as a two-step, two-pot reaction sequence. The method is useful for the production of 20-30 mCi quantities of this compound from [18F]fluoride, available in 40% radiochemical yield at end of bombardment (EOB) with a specific activity (nca ...
J R, Grierson, J M, Link, C A, Mathis, J S, Rasey, K A, Krohn   +4 more
openaire   +1 more source

Fluorine-18-Labelled Fluoropyridines: Advances in Radiopharmaceutical Design

Current Pharmaceutical Design, 2005
Positron Emission Tomography is a high-resolution, sensitive, functional imaging technique, which can efficiently give access to the distribution, pharmacokinetics and -dynamics of a drug in vivo and which can therefore advantageously play a key-role in both drug discovery and development.
openaire   +2 more sources

Recent progress in fluorine-18 labelled peptide radiopharmaceuticals

European Journal of Nuclear Medicine, 2001
The application of biologically active peptides labelled with positron-emitting nuclides has emerged as a useful and interesting field in nuclear medicine. Small synthetic receptor-binding peptides are currently the preferred agents over proteins and antibodies for diagnostic imaging of various tumours.
openaire   +2 more sources

Fluorine-18 labelled -p-

The International Journal of Applied Radiation and Isotopes, 1975
R.W. Goulding, S.W. Gunasekera
openaire   +1 more source

Fluorine‐18 Radiochemistry

Handbook of Radiopharmaceuticals, 2020
Allen F. Brooks, Katarina J. Makaravage, Jay S Wright, M. Sanford, P. Scott   +4 more
semanticscholar   +1 more source

Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis

Skeletal Radiology, 2017
M. Bassetti, M. Merelli, F. Gregorio, P. Della Siega, M. Screm, C. Scarparo, E. Righi   +6 more
semanticscholar   +1 more source